WORKSHOP CHAIRS: REGISTER NOW
Samir Khleif (Georgia University, USA)
Christian Schneider (Danish Health and Medicines Authority)
Catherine Weil (BMS, Belgium)
Wolfgang Wein (Merck Serono, Germany)
GOAL OF THE WORKSHOP
Immunotherapy of cancer is an evolving field that has not only seen drawbacks but also, more recently, indications that it could become a hallmark of future anticancer therapies. However, it bears challenges like clinical trial design issues or inadequacy of common criteria, and thus requires more specific and multidisciplinary approaches.
This workshop brings together experts from academia, industry and regulatory authorities in order to discuss experiences address hurdles and explore potential solutions.
- Immuno-oncology: putting theory to practice
- Therapeutic cancer vaccines
- Counteract immunosuppressive microenvironment of the tumor
- Cytokines & cytokine combinations
- Combination therapy
- Clinical trial design
- Immunotherapy and regulatory implications
WHO SHOULD ATTEND?
Senior decision makers from the pharmaceutical industry, representatives of regulatory bodies, representatives from academia (scientists, clinicians).